• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合光动力疗法和贝伐单抗治疗弓形虫相关性脉络膜新生血管。

Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis.

机构信息

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Tamil Nadu, India.

出版信息

Indian J Ophthalmol. 2011 Jan-Feb;59(1):62-4. doi: 10.4103/0301-4738.73728.

DOI:10.4103/0301-4738.73728
PMID:21157079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3032250/
Abstract

A 14-year-old girl presenting with visual loss in both eyes was diagnosed to have healed toxoplasma retinochoroiditis in the right eye with active choroidal neovascularization (CNV) secondary to toxoplasmosis in the left. She underwent combination photodynamic therapy (PDT) and intravitreal bevacizumab as primary treatment. PDT was performed as per the 'Treatment of Age-related Macular Degeneration by Photodynamic therapy' study protocol and was followed by intravitreal bevacizumab after 2 days. CNV regressed at 8 weeks of follow-up and remained stable at 8 months of follow-up. The initial visual acuity improved from 20/120 to 20/30. Combination therapy with PDT and intravitreal bevacizumab appears to be effective in the treatment of CNV secondary to toxoplasma retinochoroiditis.

摘要

一位 14 岁女孩因双眼视力丧失就诊,被诊断为右眼弓形虫性视网膜炎已愈合,左眼活动性脉络膜新生血管(CNV)继发于弓形虫病。她接受了联合光动力疗法(PDT)和玻璃体内贝伐单抗治疗作为一线治疗。PDT 按照“光动力疗法治疗年龄相关性黄斑变性”研究方案进行,随后在 2 天后进行玻璃体内贝伐单抗治疗。CNV 在 8 周的随访中消退,在 8 个月的随访中保持稳定。最初的视力从 20/120 提高到 20/30。PDT 和玻璃体内贝伐单抗联合治疗似乎对弓形虫性视网膜炎继发的 CNV 有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/5e6a7d587789/IJO-59-62-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/3a19966e3b5d/IJO-59-62-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/573f65b72221/IJO-59-62-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/5e6a7d587789/IJO-59-62-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/3a19966e3b5d/IJO-59-62-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/573f65b72221/IJO-59-62-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6368/3032250/5e6a7d587789/IJO-59-62-g003.jpg

相似文献

1
Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis.联合光动力疗法和贝伐单抗治疗弓形虫相关性脉络膜新生血管。
Indian J Ophthalmol. 2011 Jan-Feb;59(1):62-4. doi: 10.4103/0301-4738.73728.
2
Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis.
Acta Ophthalmol. 2009 Sep;87(6):688-90. doi: 10.1111/j.1755-3768.2008.01319.x. Epub 2008 Jul 8.
3
Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.贝伐单抗与光动力疗法治疗多灶性脉络膜炎性脉络膜新生血管的比较
Arch Ophthalmol. 2010 Sep;128(9):1100-3. doi: 10.1001/archophthalmol.2010.205.
4
Pattern electroretinographic results after photodynamic therapy alone and photodynamic therapy in combination with intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.年龄相关性黄斑变性中脉络膜新生血管单独光动力疗法及光动力疗法联合玻璃体腔注射贝伐单抗后的图形视网膜电图结果
Doc Ophthalmol. 2009 Aug;119(1):37-42. doi: 10.1007/s10633-009-9167-8. Epub 2009 Feb 19.
5
Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.玻璃体腔内注射贝伐单抗联合维替泊芬光动力疗法治疗年龄相关性黄斑变性脉络膜新生血管
Retina. 2008 May;28(5):675-81. doi: 10.1097/IAE.0b013e31816b316e.
6
Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series.玻璃体内注射贝伐单抗治疗弓形虫性视网膜脉络膜炎继发脉络膜新生血管:病例系列
Semin Ophthalmol. 2015 May;30(3):181-7. doi: 10.3109/08820538.2013.838278. Epub 2013 Oct 31.
7
Photodynamic therapy for choroidal neovascularization in young adult patients.
Int Ophthalmol. 2010 Aug;30(4):345-51. doi: 10.1007/s10792-010-9346-3. Epub 2010 Feb 2.
8
Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration: visual acuity after 1 year of follow-up.单独玻璃体内贝伐单抗与联合维替泊芬光动力疗法和玻璃体内贝伐单抗治疗年龄相关性黄斑变性脉络膜新生血管: 1 年随访后的视力
Retina. 2010 Apr;30(4):548-54. doi: 10.1097/IAE.0b013e3181bcf1b8.
9
Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).玻璃体内注射贝伐单抗(阿瓦斯汀)联合维替泊芬光动力疗法治疗年龄相关性黄斑变性相关脉络膜新生血管(IBeVe研究)
Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. doi: 10.1007/s00417-007-0557-x. Epub 2007 Feb 28.
10
Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.玻璃体内注射贝伐单抗(阿瓦斯汀)作为眼部弓形虫病继发脉络膜新生血管的一线及挽救治疗。
Int Ophthalmol. 2008 Aug;28(4):311-6. doi: 10.1007/s10792-008-9218-2. Epub 2008 Apr 10.

引用本文的文献

1
Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis.眼弓形体病的玻璃体内治疗的临床结局:系统评价和荟萃分析。
Rev Soc Bras Med Trop. 2023 May 22;56:e05522022. doi: 10.1590/0037-8682-0552-2022. eCollection 2023.
2
Choroidal neo-vascular membrane in a paediatric optic disc pit: A case report.小儿视盘小凹合并脉络膜新生血管膜:一例报告
Am J Ophthalmol Case Rep. 2022 Nov 12;28:101751. doi: 10.1016/j.ajoc.2022.101751. eCollection 2022 Dec.
3
Choroidal neovascularization in 111 eyes of children and adolescents.

本文引用的文献

1
Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.玻璃体内注射贝伐单抗(阿瓦斯汀)作为眼部弓形虫病继发脉络膜新生血管的一线及挽救治疗。
Int Ophthalmol. 2008 Aug;28(4):311-6. doi: 10.1007/s10792-008-9218-2. Epub 2008 Apr 10.
2
Choroidal neovascularisation in children.儿童脉络膜新生血管形成
Br J Ophthalmol. 2008 Apr;92(4):451-4. doi: 10.1136/bjo.2007.124586.
3
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
111 例儿童和青少年脉络膜新生血管。
Int Ophthalmol. 2022 Jan;42(1):157-166. doi: 10.1007/s10792-021-02018-2. Epub 2021 Aug 23.
4
Toxoplasma Retinochoroiditis with Chorioretinal Neovascularization in a Young Patient.一名年轻患者的伴有脉络膜视网膜新生血管的弓形虫性视网膜脉络膜炎
Case Rep Ophthalmol. 2021 Apr 16;12(1):259-263. doi: 10.1159/000512286. eCollection 2021 Jan-Apr.
5
An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.炎症性脉络膜新生血管的最新进展:流行病学、多模态成像及治疗
J Ophthalmic Inflamm Infect. 2018 Sep 12;8(1):13. doi: 10.1186/s12348-018-0155-6.
6
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study.玻璃体内注射阿柏西普治疗与脉络膜视网膜炎相关的脉络膜新生血管:一项试点研究。
Clin Ophthalmol. 2017 Jul 20;11:1315-1320. doi: 10.2147/OPTH.S132923. eCollection 2017.
7
Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor.印度人群眼中的炎症性脉络膜新生血管:病因、临床特征及抗血管内皮生长因子治疗的效果
Indian J Ophthalmol. 2017 Apr;65(4):295-300. doi: 10.4103/ijo.IJO_262_16.
8
Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis.并存的脉络膜新生血管和活动性视网膜脉络膜炎——眼部弓形虫病的一种罕见表现。
J Ophthalmic Inflamm Infect. 2015 Jul 12;5:22. doi: 10.1186/s12348-015-0051-2. eCollection 2015.
9
Choroidal neovascularization in 36 eyes of children and adolescents.36 只儿童和青少年眼的脉络膜新生血管。
Eye (Lond). 2013 Oct;27(10):1158-68. doi: 10.1038/eye.2013.155. Epub 2013 Jul 26.
10
Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.光动力疗法联合玻璃体内注射贝伐单抗治疗脉络膜骨瘤继发脉络膜新生血管患者
Korean J Ophthalmol. 2012 Dec;26(6):478-80. doi: 10.3341/kjo.2012.26.6.478. Epub 2012 Nov 12.
维替泊芬联合玻璃体内注射贝伐单抗光动力疗法治疗年龄相关性黄斑变性脉络膜新生血管
Retina. 2006 Nov-Dec;26(9):988-93. doi: 10.1097/01.iae.0000247164.70376.91.
4
Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis.维替泊芬光动力疗法治疗与弓形虫性视网膜脉络膜炎相关的脉络膜新生血管
Retina. 2006 Apr;26(4):396-403. doi: 10.1097/01.iae.0000238552.76412.ae.
5
Clinical features and prognosis in ocular toxoplasmosis.眼部弓形虫病的临床特征与预后
Jpn J Ophthalmol. 2004 Jul-Aug;48(4):386-91. doi: 10.1007/s10384-003-0069-0.
6
Visual outcome after surgical removal of choroidal neovascularization in pediatric patients.小儿患者脉络膜新生血管手术切除后的视力预后
Arch Ophthalmol. 2000 Oct;118(10):1373-8. doi: 10.1001/archopht.118.10.1373.
7
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管:两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法(TAP)研究组
Arch Ophthalmol. 1999 Oct;117(10):1329-45.
8
The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome.黄斑下脉络膜新生血管的手术切除。向内生长部位作为视力预后的预测指标。
Retina. 1996;16(3):190-5. doi: 10.1097/00006982-199616030-00002.
9
Subretinal neovascularization in children and adolescents.儿童和青少年的视网膜下新生血管形成
J Pediatr Ophthalmol Strabismus. 1995 May-Jun;32(3):178-82. doi: 10.3928/0191-3913-19950501-11.
10
Subretinal neovascularization in chronic uveitis.慢性葡萄膜炎中的视网膜下新生血管形成
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;215(1):43-51. doi: 10.1007/BF00413395.